MGFA patient conference highlights wellness education, science
More than 500 members of the myasthenia gravis (MG) community are expected at a conference featuring strategies for patient education,…
Articles by Marisa Wexler, MS
Inebilizumab eases gMG symptoms in anti-AChR antibody patients
One year of treatment with inebilizumab eased symptoms and improved daily functioning for people with generalized myasthenia gravis…
Repeated cycles of Rystiggo don’t increase safety problem risk
Repeated cycles of Rystiggo (rozanolixizumab-noli) do not increase the risk of safety problems in people with generalized myasthenia…
Rituximab seen as safe, effective in treating MuSK-positive MG
Rituximab can safely and effectively control myasthenia gravis (MG) in patients with antibodies against muscle-specific kinase or MuSK,…
Medication for arthritis may help treat MG, early study suggests
Tofacitinib, an approved medication for some types of inflammatory arthritis and inflammatory bowel disease, may also help treat myasthenia…
Top-line findings in Phase 3 batoclimab trial likely by late March
Top-line results from a Phase 3 clinical trial of batoclimab in people with generalized myasthenia gravis (gMG) are expected…
Nipocalimab bests placebo at easing gMG severity in Phase 3 trial
Nipocalimab outperformed a placebo at easing the severity of generalized myasthenia gravis (gMG) in a Phase 3 clinical…
ARGX-119 may aid muscle strength in some people with MuSK MG
Treatment with ARGX-119, an experimental therapy being developed by Argenx, led to improvements in muscle strength and survival…
Top 10 myasthenia gravis stories of 2024
Throughout 2024, the team at Myasthenia Gravis News has brought you the latest updates on research advances and treatment options…
Disease crises linked to more hospital time for MG patients
People with myasthenia gravis (MG) who experience exacerbations tend to require longer and more frequent hospital stays, according to…